Acral Lentiginous Melanoma (ALM) Rates Higher in Southeast Asian Individuals than Other Asian Groups
source: unsplash.com

Acral Lentiginous Melanoma (ALM) Rates Higher in Southeast Asian Individuals than Other Asian Groups

  In the past, there has been limited research exploring the presentation of melanoma in Asian American and Pacific Islanders (AAPIs). Recent research has sought to explore this relationship and…

Continue Reading Acral Lentiginous Melanoma (ALM) Rates Higher in Southeast Asian Individuals than Other Asian Groups
Rare Community Profiles: St. Jude Children’s Research Hospital Opens 45,000 Square Foot “Family Commons” to Support and Offer Comfort to Families
source: unsplash.com

Rare Community Profiles: St. Jude Children’s Research Hospital Opens 45,000 Square Foot “Family Commons” to Support and Offer Comfort to Families

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: St. Jude Children’s Research Hospital Opens 45,000 Square Foot “Family Commons” to Support and Offer Comfort to Families

Mutual Trust Between Doctors and Parents of Children with Rare Diseases Means Optimum Care for the Child

The complexity of rare diseases makes communication between adults involved with the care of these children a vital tool. Communication and mutual trust are of the utmost importance. About the…

Continue Reading Mutual Trust Between Doctors and Parents of Children with Rare Diseases Means Optimum Care for the Child
Ipsen Pushes for FDA Approval of Palovarotene for FOP
source: pixabay.com

Ipsen Pushes for FDA Approval of Palovarotene for FOP

In 2022, the U.S. Food and Drug Administration (FDA) examined the potential of approving palovarotene, a selective RARγ agonist, for the treatment of fibrodysplasia ossificans progressiva (FOP). However, the FDA…

Continue Reading Ipsen Pushes for FDA Approval of Palovarotene for FOP
MDA Clinical & Scientific Conference: Givinostat Improves Physical Function and Mobility in DMD
Source: https://pixabay.com/en/stairway-staircase-stairs-outdoors-828883/

MDA Clinical & Scientific Conference: Givinostat Improves Physical Function and Mobility in DMD

The Muscular Dystrophy Association (MDA) recently held its MDA Clinical & Scientific Conference in March 2023. During the conference, stakeholders in the community discussed research trends and clinical practices associated…

Continue Reading MDA Clinical & Scientific Conference: Givinostat Improves Physical Function and Mobility in DMD